| P50 | author | William D. Steers | Q8007518 |
| P2093 | author name string | Adam P. Klausner | |
| P2860 | cites work | The method of bladder drainage in spinal cord injury patients may influence the histological changes in the mucosa of neuropathic bladder - a hypothesis | Q24791982 |
| | Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence | Q30906698 |
| | Efficacy and safety of terazosin to improve voiding in spinal cord injury patients | Q33174606 |
| | Reused silicone catheter for clean intermittent catheterization (CIC): is it safe for spinal cord-injured (SCI) men? | Q33205418 |
| | Catheter-associated urinary tract infections | Q34125132 |
| | Iatrogenic hypospadias--a preventable injury? | Q34465041 |
| | A systematic review of the management of autonomic dysreflexia after spinal cord injury. | Q34974209 |
| | Bladder cancer in patients with spinal cord injury. | Q35678889 |
| | Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra | Q36018771 |
| | Correlation between clinical neurological data and urodynamic function in spinal cord injured patients | Q36859640 |
| | Antimuscarinics for the treatment of overactive bladder: a review of central nervous system effects | Q37016329 |
| | Contemporary role of suprapubic cystostomy in treatment of neuropathic bladder dysfunction in spinal cord injured patients | Q37190579 |
| | Urinary tract infection in persons with spinal cord injury | Q40507058 |
| | Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction | Q40667303 |
| | Fate of upper urinary tracts in patients with indwelling catheters after spinal cord injury | Q40849912 |
| | Bladder function in healthy volunteers: ambulatory monitoring and conventional urodynamic studies | Q41040579 |
| | Clinical effect of alpha-1 antagonism by terazosin on external and internal urinary sphincter function | Q42692522 |
| | Intermittent urethral self-catheterisation: long term results (bacteriological evolution, continence, acceptance, complications). | Q43720199 |
| | Can higher doses of oxybutynin improve efficacy in neurogenic bladder? | Q44721048 |
| | Bladder hypocompliance in the spinal cord injury population | Q45035168 |
| | Pharmacological modulation of the pontine micturition center | Q48738638 |
| | The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. | Q53317478 |
| | Voided volumes: normal values and relation to lower urinary tract symptoms in elderly men, a community-based study. | Q53325241 |
| | Ambulatory monitoring and conventional cystometry in asymptomatic female volunteers. | Q53367920 |
| | The impact of urodynamic parameters on the upper tracts of spinal cord injured men who void reflexly. | Q53951128 |
| | Spinal-injured neuropathic bladder antisepsis (SINBA) trial | Q60736207 |
| | Complications of Permanent Bladder Catheter Drainage in Spinal Cord Injury Patients | Q67015610 |
| | The development of urologic complications in relationship to bladder pressure in spinal cord injured patients | Q70543443 |
| | Urodynamic studies in evaluating detrusor sphincter dyssynergia and their effects on the treatment | Q70795149 |
| | Clean intermittent catheterisation from the acute period in spinal cord injury patients. Long term evaluation of urethral and genital tolerance | Q70958311 |
| | The effect of terazosin on bladder function in the spinal cord injured patient | Q72670853 |
| | Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies | Q73042719 |
| | Terazosin for vesicosphincter dyssynergia in spinal cord-injured male patients | Q73394820 |
| | Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients | Q73593452 |
| | Bladder leak point pressure: the measure for sphincterotomy success in spinal cord injured patients with external detrusor-sphincter dyssynergia | Q74738540 |
| | Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia | Q77346954 |
| | Risk factors for development of proteinuria in chronic spinal cord injury | Q77357921 |
| | Botulinum A Toxin Urethral Injection for the Treatment of Lower Urinary Tract Dysfunction | Q79130746 |
| | Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial | Q82975823 |
| | Surgical management of urethral damage in neurologically impaired female patients with chronic indwelling catheters | Q95802626 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurogenic bladder | Q2339038 |
| P304 | page(s) | 111-120 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Medical Clinics of North America | Q15761972 |
| P1476 | title | The neurogenic bladder: an update with management strategies for primary care physicians | |
| | The Neurogenic Bladder: An Update with Management Strategies for Primary Care Physicians | |
| P478 | volume | 95 | |